Exact Mass: 482.0799

Exact Mass Matches: 482.0799

Found 18 metabolites which its exact mass value is equals to given mass value 482.0799, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Regorafenib

4-(4-(((4-chloro-3-(Trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide

C21H15ClF4N4O3 (482.0769)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Regorafenib (BAY 73-4506) is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1, respectively. Regorafenib shows very robust antitumor and antiangiogenic activity[1].

   

Seletalisib

3-{8-chloro-3-[2,2,2-trifluoro-1-({pyrido[3,2-d]pyrimidin-4-yl}amino)ethyl]quinolin-2-yl}pyridin-1-ium-1-olate

C23H14ClF3N6O (482.087)


   

2-(alpha-Hydroxypropyl)thiamine diphosphate; 2-Hydroxypropyl-ThPP

2-(alpha-Hydroxypropyl)thiamine diphosphate; 2-Hydroxypropyl-ThPP

C15H24N4O8P2S (482.079)


   

Fucodiphlorethol C

Fucodiphlorethol C

C24H18O11 (482.0849)


   

fucodiphloroethol G

fucodiphloroethol G

C24H18O11 (482.0849)


   

Regorafenib (BAY 73-4506)

Regorafenib (BAY 73-4506)

C21H15ClF4N4O3 (482.0769)


   

(-)-1 6-BIS(2-CHLOROPHENYL)-1 6-DIPHENY&

(-)-1 6-BIS(2-CHLOROPHENYL)-1 6-DIPHENY&

C30H20Cl2O2 (482.084)


   

(-)-1,2-BIS((2S,5S)-2,5-DIETHYLPHOSPHOLANO)ETHANE

(-)-1,2-BIS((2S,5S)-2,5-DIETHYLPHOSPHOLANO)ETHANE

C30H20Cl2O2 (482.084)


   

Seletalisib

Seletalisib

C23H14ClF3N6O (482.087)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor

   

Disperse Brown 19

Disperse Brown 19

C20H20Cl2N4O6 (482.076)


   

(2-NAPHTHYLMETHYL)(TRIPHENYL)PHOSPHONIUM BROMIDE

(2-NAPHTHYLMETHYL)(TRIPHENYL)PHOSPHONIUM BROMIDE

C29H24BrP (482.0799)


   

2-(4-(2-((3-(5-(Pyridin-2-Ylthio)thiazol-2-Yl)ureido)methyl)-1h-Imidazol-4-Yl)phenoxy)acetic Acid

2-(4-(2-((3-(5-(Pyridin-2-Ylthio)thiazol-2-Yl)ureido)methyl)-1h-Imidazol-4-Yl)phenoxy)acetic Acid

C21H18N6O4S2 (482.0831)


   

Regorafenib

Regorafenib

C21H15ClF4N4O3 (482.0769)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Regorafenib (BAY 73-4506) is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRβ, Kit, RET and Raf-1, respectively. Regorafenib shows very robust antitumor and antiangiogenic activity[1].

   

2,3-Dihydroxybenzoyl 5-adenylate(1-)

2,3-Dihydroxybenzoyl 5-adenylate(1-)

C17H17N5O10P- (482.0713)


Conjugate base of 2,3-dihydroxybenzoyl 5-adenylate.

   

(3,4-Dihydroxybenzoate)adenylate

(3,4-Dihydroxybenzoate)adenylate

C17H17N5O10P- (482.0713)


   

[2-(acetyloxy)-2-(9-{[(2E)-2-methylbut-2-enoyl]oxy}-2-oxo-2H,8H,9H-furo[2,3-h]chromen-8-yl)propoxy]sulfonic acid

[2-(acetyloxy)-2-(9-{[(2E)-2-methylbut-2-enoyl]oxy}-2-oxo-2H,8H,9H-furo[2,3-h]chromen-8-yl)propoxy]sulfonic acid

C21H22O11S (482.0883)


   

5'-[2,4-dihydroxy-6-(2,4,6-trihydroxyphenoxy)phenoxy]-[1,1'-biphenyl]-2,3',4,6-tetrol

5'-[2,4-dihydroxy-6-(2,4,6-trihydroxyphenoxy)phenoxy]-[1,1'-biphenyl]-2,3',4,6-tetrol

C24H18O11 (482.0849)


   

[(6s,8as)-8a-(chloromethyl)-8-hydroxy-1-methyl-2,5-dioxo-3h,6h-imidazo[1,2-a]pyrazin-6-yl]methyl 2,3-dihydroxy-2-(hydroxymethyl)-1,4-benzoxazine-5-carboxylate

[(6s,8as)-8a-(chloromethyl)-8-hydroxy-1-methyl-2,5-dioxo-3h,6h-imidazo[1,2-a]pyrazin-6-yl]methyl 2,3-dihydroxy-2-(hydroxymethyl)-1,4-benzoxazine-5-carboxylate

C19H19ClN4O9 (482.0841)